Patient Satisfaction in Cutaneous Surgery
NCT01535963 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 354
Last updated 2025-01-31
Summary
The primary objective of this study is to measure the overall level of satisfaction in patients after cutaneous surgery in 4 different categories, including the surgeon, facility, procedure and recovery and outcome.
Conditions
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Murad Alam, MD · Northwestern University
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-06-30
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- United States
Study Locations
More Related Trials
-
Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin
NCT05066113 ·Status: RECRUITING ·Phase: NA
-
Safety & Performance Study of Verruca Treatment Device
NCT01536834 ·Status: COMPLETED ·Phase: NA
-
Salicylic Acid Versus Cryotherapy for the Treatment of HPV1-induced Plantar Warts
NCT05617950 ·Status: UNKNOWN ·Phase: NA
-
Assessment of Squamous Cell Carcinoma antigen2 in Verruca Vulgaris
NCT05409365 ·Status: UNKNOWN
-
Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva
NCT00504023 ·Status: COMPLETED ·Phase: NA
-
Phase I Clinical Study for Evaluation of Pharmacokinetic, Safety, Tolerance of Norcantharidin Lipid Microsphere for Injection in Patients With Solid Tumor
NCT04673396 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase I/II Double-blind Safety and Efficacy Evaluation of Nowarta110 in Patients With Plantar Warts
NCT02338336 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision
NCT06664151 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides
NCT05838599 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Comparison of Therapeutic Efficacy Between Intralesional Bleomycin and Cryotherapy in Plantar Warts
NCT05752435 ·Status: COMPLETED ·Phase: NA
-
Promoting Human Papillomavirus (HPV) Vaccination Through African American Beauty Salons
NCT01461408 ·Status: COMPLETED ·Phase: NA
-
A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Patients With Hidradenitis Suppurativa
NCT06932003 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
NCT05026138 ·Status: RECRUITING
-
Pathophysiological Basis of Hidradenitis Suppurativa
NCT06370052 ·Status: NOT_YET_RECRUITING
-
Treatment of Dermatofibrosarcoma Protuberans in Patients 10 Years and Younger
NCT03381846 ·Status: COMPLETED ·Phase: NA
-
Interleukin 4 and Interferon Gamma Predictors of Human Papillomavirus Immunotherapy in Warts
NCT05100043 ·Status: COMPLETED
-
Biomarkers of Lichen Sclerosus
NCT03561428 ·Status: UNKNOWN
-
Microwave Treatment of Common and Plantar Warts
NCT05371834 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Development of Dermatology-related Quality of Life Assessment in Patients Treated With Epidermal Growth Factor Receptor (EGFR) Inhibitors
NCT01015326 ·Status: COMPLETED
-
Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa
NCT07244510 ·Status: RECRUITING ·Phase: PHASE2
-
Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts
NCT04814446 ·Status: RECRUITING ·Phase: PHASE3
-
Laser Versus Cryotherapy for the Treatment of Recalcitrant Warts
NCT05616078 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Short-term Treatment Satisfaction in Hidradenitis Suppurativa Patients Initiated on Cosentyx in Routine Clinical Practice in Saudi Arabia
NCT06785779 ·Status: RECRUITING
-
Study to Compare Two Treatments for Axillary Hidradenitis Suppurativa: Carbon Dioxide Laser Versus Surgical Deroofing
NCT02163746 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of EXC 001 in Subjects Who Have Participated in Prior Studies of EXC 001
NCT01494922 ·Status: COMPLETED ·Phase: PHASE2